Pinyunin B

Details

Top
Internal ID fa1efadb-69c2-4566-a4ee-763a9606c52a
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Diterpenoids
IUPAC Name (1R,4aR,4bR,10aR)-1,4a-dimethyl-6-oxo-7-propan-2-yl-3,4,4b,5,10,10a-hexahydro-2H-phenanthrene-1-carboxylic acid
SMILES (Canonical) CC(C)C1=CC2=CCC3C(C2CC1=O)(CCCC3(C)C(=O)O)C
SMILES (Isomeric) CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1=O)(CCC[C@@]3(C)C(=O)O)C
InChI InChI=1S/C20H28O3/c1-12(2)14-10-13-6-7-17-19(3,15(13)11-16(14)21)8-5-9-20(17,4)18(22)23/h6,10,12,15,17H,5,7-9,11H2,1-4H3,(H,22,23)/t15-,17+,19+,20+/m0/s1
InChI Key MRGKHDWUXCFJLK-JQERWDHBSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C20H28O3
Molecular Weight 316.40 g/mol
Exact Mass 316.20384475 g/mol
Topological Polar Surface Area (TPSA) 54.40 Ų
XlogP 3.90
Atomic LogP (AlogP) 4.39
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Pinyunin B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9961 99.61%
Caco-2 + 0.7367 73.67%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.5429 54.29%
Subcellular localzation Mitochondria 0.9052 90.52%
OATP2B1 inhibitior - 0.8631 86.31%
OATP1B1 inhibitior - 0.3260 32.60%
OATP1B3 inhibitior + 0.8126 81.26%
MATE1 inhibitior - 0.8000 80.00%
OCT2 inhibitior + 0.6500 65.00%
BSEP inhibitior + 0.6682 66.82%
P-glycoprotein inhibitior - 0.8797 87.97%
P-glycoprotein substrate - 0.7831 78.31%
CYP3A4 substrate + 0.5741 57.41%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.9018 90.18%
CYP3A4 inhibition - 0.8315 83.15%
CYP2C9 inhibition - 0.8584 85.84%
CYP2C19 inhibition - 0.8273 82.73%
CYP2D6 inhibition - 0.9514 95.14%
CYP1A2 inhibition - 0.8772 87.72%
CYP2C8 inhibition - 0.8762 87.62%
CYP inhibitory promiscuity - 0.9345 93.45%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5882 58.82%
Eye corrosion - 0.9942 99.42%
Eye irritation - 0.8046 80.46%
Skin irritation + 0.6222 62.22%
Skin corrosion - 0.9601 96.01%
Ames mutagenesis - 0.8600 86.00%
Human Ether-a-go-go-Related Gene inhibition - 0.3885 38.85%
Micronuclear - 0.7600 76.00%
Hepatotoxicity + 0.5041 50.41%
skin sensitisation + 0.5846 58.46%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity + 0.7750 77.50%
Nephrotoxicity - 0.5750 57.50%
Acute Oral Toxicity (c) III 0.7802 78.02%
Estrogen receptor binding - 0.5227 52.27%
Androgen receptor binding - 0.5555 55.55%
Thyroid receptor binding + 0.6784 67.84%
Glucocorticoid receptor binding + 0.6527 65.27%
Aromatase binding - 0.6451 64.51%
PPAR gamma + 0.8243 82.43%
Honey bee toxicity - 0.8961 89.61%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.7900 79.00%
Fish aquatic toxicity + 1.0000 100.00%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.39% 91.11%
CHEMBL2581 P07339 Cathepsin D 92.24% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.09% 94.45%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.29% 95.56%
CHEMBL253 P34972 Cannabinoid CB2 receptor 90.14% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 89.54% 96.09%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 87.83% 90.71%
CHEMBL221 P23219 Cyclooxygenase-1 87.27% 90.17%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 86.04% 99.23%
CHEMBL3351 Q13085 Acetyl-CoA carboxylase 1 84.82% 93.04%
CHEMBL4040 P28482 MAP kinase ERK2 84.81% 83.82%
CHEMBL340 P08684 Cytochrome P450 3A4 82.28% 91.19%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.91% 97.09%

Cross-Links

Top
PubChem 52325861
NPASS NPC15518
LOTUS LTS0188239
wikiData Q105170551